SI
Shoulder Innovations Inc
NYSE · Health Care
$12.74
+0.17 (+1.35%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 106.70M | 98.23M | 112.58M |
| Net Income | 12.47M | 11.86M | 14.74M |
| EPS | — | — | — |
| Profit Margin | 11.7% | 12.1% | 13.1% |
| Rev Growth | +24.4% | +5.2% | +19.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 75.93M | 85.59M | 79.56M |
| Total Equity | 198.08M | 194.16M | 180.23M |
| D/E Ratio | 0.38 | 0.44 | 0.44 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 21.26M | 19.36M | 18.97M |
| Free Cash Flow | 14.90M | 16.21M | 20.64M |